比较前列腺切除术后由FPMRS指导的当面盆底治疗项目与无监督盆底锻炼的疗效
该回顾性研究比较前列腺切除术后接受FPMRS专科医师监督的12个月盆底肌训练(PFMT)与标准无监督家庭盆底锻炼(UPFE)的失禁结局,共纳入40例男性。PFMT组在6个月和12个月时的SUI症状评分均显著优于UPFE组,但12个月时SUI治愈概率、每日护垫使用量及生活质量评分两组无显著差异。
要点
- PFMT组6个月SUI症状评分0.81±0.21 vs UPFE组1.75±0.34(P=0.014),12个月0.72±0.17 vs 1.67±0.30(P=0.004)
- 12个月随访时PFMT组11例(55%)报告无SUI vs UPFE组4例(20%)
- 12个月SUI治愈预测概率PFMT组0.52±0.14 vs UPFE组0.23±0.13(P=0.14),未达统计学显著
核心结论
- 当面、由FPMRS指导的PFMT与机器人辅助腹腔镜前列腺切除术后SUI症状评分改善相关,该效果持续至12个月随访。
研究设计与样本
- 回顾性分析前瞻性收集的纵向结局数据,比较接受12个月PFMT项目(FPMRS专科医师监督)与UPFE的患者,随访至12个月。
- 共纳入40例男性患者。
- 主要结局为ICIQ-MLUTS SUI域评分(SDS),次要结局包括每日护垫使用量(PPD)、SUI治愈(SDS=0)及生活质量评分(IIQ-7)。
- 采用多水平混合效应线性回归对SDS随时间变化建模。
主要发现
- PFMT组与UPFE组患者特征比较均无差异(P=NS)。
- 6个月时平均预测SDS PFMT组0.81±0.21 vs UPFE组1.75±0.34(P=0.014);12个月时PFMT组0.72±0.17 vs UPFE组1.67±0.30(P=0.004)。
- 12个月随访时报告无SUI者PFMT组11例(55%) vs UPFE组4例(20%)。
- 12个月SUI治愈预测概率PFMT组0.52±0.14 vs UPFE组0.23±0.13(P=0.14)。
- 12个月随访时平均预测PPD PFMT组0.19±0.10 vs UPFE组0.79±0.33,IIQ评分PFMT组2.86±0.86 vs UPFE组2.55±1.07,均P=NS。
关键数值与推荐
- PFMT组6个月平均预测SDS为0.81±0.21,UPFE组为1.75±0.34(P=0.014)。
- PFMT组12个月平均预测SDS为0.72±0.17,UPFE组为1.67±0.30(P=0.004)。
- 12个月SUI治愈预测概率PFMT组0.52±0.14 vs UPFE组0.23±0.13(P=0.14)。
- 12个月平均预测PPD PFMT组0.19±0.10 vs UPFE组0.79±0.33(P=NS)。
- 12个月平均预测IIQ评分PFMT组2.86±0.86 vs UPFE组2.55±1.07(P=NS)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare comprehensive continence outcomes in patients receiving pelvic floor muscle training (PFMT) vs standard unsupervised home pelvic floor exercise therapy (UPFE). METHODS: As part of the UVA prostatectomy functional outcomes program, participating patients complete a 12-month PFMT program under FPMRS specialist supervision. We performed a retrospective review of prospectively collected longitudinal outcomes in patients receiving PFMT vs UPFE through 12-month follow-up. Primary study outcome was ICIQ-MLUTS SUI domain score (SDS). Secondary outcomes included daily pad use (PPD), SUI Cure (SDS=0), and quality of life score (IIQ-7). Multilevel mixed effects linear regression was used to model SDS over time. RESULTS: Analysis included 40 men. No difference in patient characteristics was seen in comparison of PFMT vs UPFE cohorts (P = NS, all comparisons). Mean predicted SDS was significantly better in the PFMT vs UPFE cohorts at 6-month (0.81 ± 0.21 vs 1.75 ± 0.34, respectively) (P = .014) and 12-month (0.72 ± 0.17 vs 1.67 ± 0.30, respectively) (P = .004) time points. At 12-month follow-up, 11 (55%) vs 4 (20%) patients reported absence of SUI in PFMT vs UPFE cohorts, respectively. Predicted probabilities of SUI cure in PFMT vs UPFE cohorts at 12months were 0.52 ± 0.14 vs 0.23 ± 0.13, respectively (P = .14). At 12-month follow-up, the mean predicted PPD and IIQ score was 0.19 ± 0.10 vs 0.79 ± 0.33 and 2.86 ± 0.86 vs 2.55 ± 1.07 in PFMT vs UPFE cohorts, respectively (P = NS). CONCLUSION: In-person, FMPRS-directed PFMT is associated with improved SUI domain scores following robotic-assisted laparoscopic prostatectomy, a finding durable through 12-month follow-up.
引用
- Rapp DE, Farhi J, DeNovio A, et al. Comparison of In-person FPMRS-directed Pelvic Floor Therapy Program Versus Unsupervised Pelvic Floor Exercises Following Prostatectomy. Urology. 2023. PMID: 37353089. doi:10.1016/j.urology.2023.06.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。